207940.KS vs. ARGX
207940.KS (Samsung Biologics Co Ltd) and ARGX (argenx SE) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, 207940.KS returned 0.00%/yr vs 35.90%/yr for ARGX. At a correlation of -0.03, they often move in opposite directions.
Performance
207940.KS vs. ARGX - Performance Comparison
Loading charts...
Different Trading Currencies
207940.KS is traded in KRW, while ARGX is traded in USD. To make them comparable, the ARGX values have been converted to KRW using the latest available exchange rates.
Returns By Period
207940.KS
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- 0.00%
- 5Y*
- 0.00%
- 10Y*
- —
ARGX
- 1D
- 7.62%
- 1M
- 19.02%
- YTD
- 14.70%
- 6M
- 4.65%
- 1Y
- 76.68%
- 3Y*
- 38.82%
- 5Y*
- 35.90%
- 10Y*
- —
207940.KS vs. ARGX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
207940.KS Samsung Biologics Co Ltd | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 51.80% | 12.03% | 4.18% | 94.24% |
ARGX argenx SE | 14.70% | 33.60% | 84.31% | 3.28% | 14.30% | 30.46% | 72.45% | 73.43% | 58.72% | 159.44% |
Correlation
The correlation between 207940.KS and ARGX is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.03 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.02 |
Correlation (All Time) Calculated using the full available price history since May 19, 2017 | -0.03 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
207940.KS vs. ARGX — Risk / Return Rank
207940.KS
ARGX
207940.KS vs. ARGX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Samsung Biologics Co Ltd (207940.KS) and argenx SE (ARGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| 207940.KS | ARGX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.53 | ||
| Sortino ratioReturn per unit of downside risk | -2.92 | ||
| Omega ratioGain probability vs. loss probability | 1.54 | 1.43 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | 0.00 | 2.91 | -2.91 |
| Martin ratioReturn relative to average drawdown | 0.00 | 7.53 | -7.53 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| 207940.KS | ARGX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.00 | 2.53 | -2.53 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.00 | 0.93 | -0.93 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.45 | 1.11 | -0.65 |
Drawdowns
207940.KS vs. ARGX - Drawdown Comparison
The maximum 207940.KS drawdown since its inception was -57.28%, which is greater than ARGX's maximum drawdown of -37.35%. Use the drawdown chart below to compare losses from any high point for 207940.KS and ARGX.
Loading charts...
Drawdown Indicators
| 207940.KS | ARGX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -57.28% | -37.35% | -19.93% |
Max Drawdown (1Y)Largest decline over 1 year | -34.96% | -26.50% | -8.46% |
Max Drawdown (3Y)Largest decline over 3 years | -34.96% | -37.35% | +2.39% |
Max Drawdown (5Y)Largest decline over 5 years | -34.96% | -37.35% | +2.39% |
Current DrawdownCurrent decline from peak | -34.96% | 0.00% | -34.96% |
Average DrawdownAverage peak-to-trough decline | -10.10% | -10.18% | +0.08% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.52% | 10.21% | +16.31% |
Volatility
207940.KS vs. ARGX - Volatility Comparison
The current volatility for Samsung Biologics Co Ltd (207940.KS) is 0.00%, while argenx SE (ARGX) has a volatility of 12.74%. This indicates that 207940.KS experiences smaller price fluctuations and is considered to be less risky than ARGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| 207940.KS | ARGX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.00% | 12.74% | -12.74% |
Volatility (6M)Calculated over the trailing 6-month period | 0.00% | 21.94% | -21.94% |
Volatility (1Y)Calculated over the trailing 1-year period | 65.29% | 30.45% | +34.84% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.15% | 38.81% | -9.66% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 36.04% | 50.14% | -14.10% |
Dividends
207940.KS vs. ARGX - Dividend Comparison
Neither 207940.KS nor ARGX has paid dividends to shareholders.
Financials
207940.KS vs. ARGX - Financials Comparison
This section allows you to compare key financial metrics between Samsung Biologics Co Ltd and argenx SE. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
207940.KS and ARGX have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for 207940.KS and ARGX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer